Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2 | Cellular & Molecular Immunology
Dairy | Free Full-Text | Bacterial Endotoxins and Their Role in Periparturient Diseases of Dairy Cows: Mucosal Vaccine Perspectives
Vaccines | Free Full-Text | Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4
Measles outbreak in the Philippines: epidemiological and clinical characteristics of hospitalized children, 2016-2019 - The Lancet Regional Health – Western Pacific
Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection | NEJM
Vaccines | Free Full-Text | Towards a Four-Component GMMA-Based Vaccine against Shigella
New Insights on the Adjuvant Properties of the Leishmania infantum Eukaryotic Initiation Factor
Vaccines | Free Full-Text | Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Immunization of Rabbits with a Quadrivalent Shigella Bioconjugate Vaccine Induces Functional Antibodies Reactive with Shigella Isolates from Kenya | mSphere
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM
Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy | Scientific Reports
New strategies for Leptospira vaccine development based on LPS removal | PLOS ONE
PDF) Vaccination of mice with lipopolysaccharide (LPS) and LPS-derived immuno-conjugates from
Novel multi‐component vaccine approaches for Burkholderia pseudomallei - Morici - 2019 - Clinical & Experimental Immunology - Wiley Online Library
Frontiers | Precision Vaccine Development: Cues From Natural Immunity
Recent advances in the production of recombinant glycoconjugate vaccines | npj Vaccines
Vaccines | Free Full-Text | Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
Vaccines | Free Full-Text | A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
Vaccines | Free Full-Text | An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Immunization effect of lipopolysaccharide antigen in conjugation with PLGA nanoparticles as a nanovaccine against Brucella melitensis infection - ScienceDirect
Frontiers | Outer Membrane Vesicle Induction and Isolation for Vaccine Development
IJMS | Free Full-Text | Shigella Outer Membrane Vesicles as Promising Targets for Vaccination
